In line with existing literature, familial segregation of the PAX5 variant demonstrated high but incomplete penetrance, as two leukemia‐free mutation carriers displayed only subclinical B lymphocyte maturation abnormalities without hypogammaglobulinemia. This evidence concerns the gene PAX5 and leukemia.